Text and Data Mining valid from 2015-04-21
Received: 17 October 2014
Revised: 24 March 2015
Accepted: 4 April 2015
First Online: 21 April 2015
: The author declares the following competing interests: Baronova (consulting fee and travel to present abstract, Consultant), Basic Research (consulting fees and travel to meeting, speaker at meeting and Consultant), Diabetic Living (Editorial Board honorarium, Editorial Board member), Eisai Inc. (consulting fee, Consultant), General Nutrition Corporation (consulting fee, Consultant), Jenny Craig (honorarium, Medical Advisory Board), Microbiome Therapeutics (Stock options, Advisor), NeuroQuest (Stock and licensed patent, Stockholder), Novo Nordisk (Honorarium, Scientific Advisory Board), Obalon Therapeutics (consulting fee and travel to meeting, Advisor), Orexigen Therapeutics (honorarium, Scientific Advisory Board), Origin BioMed Inc. (stock, Stockholder and former Advisor), Pam Labs (honorarium, Scientific Advisory Board), Plensat (stock, Advisor) and Zafgen Inc. (honorarium, Scientific Advisory Board).